Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127671743 | 12767174 | 3 | F | 20160927 | 20160921 | 20160929 | EXP | GB-JNJFOC-20160916364 | JANSSEN | JONES N. SEPSIS DURING IMMUNOSUPPRESSION FOR SIGHT-THREATENING UVEITIS: THE FLIP SIDE. OCULAR IMMUNOLOGY INFLAMMATION 2016:1-4. | 61.00 | YR | A | M | Y | 0.00000 | 20160929 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127671743 | 12767174 | 1 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | AT WEEKS 0, 2, AND 6, AND 8 WEEKLY THEREAFTER | Y | N | 103772 | 5 | MG/KG | LYOPHILIZED POWDER | |||||
| 127671743 | 12767174 | 2 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | Y | 0 | 2.5 | G | UNSPECIFIED | |||||||
| 127671743 | 12767174 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 0 | 1.5 | MG/KG | UNSPECIFIED | ||||||||
| 127671743 | 12767174 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 0 | 20 | MG | UNSPECIFIED | QD | |||||||
| 127671743 | 12767174 | 5 | C | TRIAMCINOLONE | TRIAMCINOLONE | 1 | Ophthalmic | U | 0 | UNSPECIFIED | |||||||||
| 127671743 | 12767174 | 6 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | U | 0 | 1 | G | UNSPECIFIED | TID | ||||||
| 127671743 | 12767174 | 7 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
| 127671743 | 12767174 | 8 | C | SULFAMETHOXAZOLE | SULFAMETHOXAZOLE | 1 | Unknown | U | 0 | 480 | MG | UNSPECIFIED | TIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127671743 | 12767174 | 1 | Uveitis |
| 127671743 | 12767174 | 2 | Immunosuppression |
| 127671743 | 12767174 | 3 | Uveitis |
| 127671743 | 12767174 | 4 | Uveitis |
| 127671743 | 12767174 | 6 | Uveitis |
| 127671743 | 12767174 | 7 | Uveitis |
| 127671743 | 12767174 | 8 | Lymphopenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127671743 | 12767174 | HO |
| 127671743 | 12767174 | OT |
| 127671743 | 12767174 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127671743 | 12767174 | Intestinal ischaemia | |
| 127671743 | 12767174 | Intestinal obstruction | |
| 127671743 | 12767174 | Multiple organ dysfunction syndrome | |
| 127671743 | 12767174 | Off label use | |
| 127671743 | 12767174 | Pneumonia | |
| 127671743 | 12767174 | Product use issue | |
| 127671743 | 12767174 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |